Ledger.Open graph →
SEC Form D · filed June 28, 2023

Cytosolix, Inc

Offering
$6.6M
Sold
$6.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TOLLAND, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jason J. Whitmire · Berlin, 2MDirectorErin Fahy · San Antonio, TXDirectorJohn J. Deacon · Tolland, CTExec · DirectorColin J. Foster · Amesbury, MAExec · DirectorAlex J. Brunicki · London, United KingdomDirectorShamus A. Shamerdyke · Vero Beach, FLDirectorJohn J. Deacon · Tolland, CTExec · DirectorColin J. Foster · Amesbury, MAExec · DirectorAlex J. Brunicki · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗